4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]di azepine derivatives

Details for Australian Patent Application No. 2007299129 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wostl, Wolfgang; Jakob-Roetne, Roland; Flohr, Alexander

Agent Davies Collison Cave

Pub. Number AU-A-2007299129

PCT Pub. Number WO2008/034735

Priority 06120956.5 20.09.06 EP

Filing date 11 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 31/5513 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 243/14 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/034735 Priority application(s): WO2008/034735

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299130-Oxindole derivatives as anticancer agents

2007299081-A process for the manufacture of carbon disulphide